Lucid Diagnostics Inc. (LUCD)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

0 2M 4M 6M Q2 '22: 689K Q3 '22: 565K Q4 '22: 377K Q1 '23: 634K Q2 '23: 793K Q3 '23: 1.5M Q4 '23: 2.4M Q1 '24: 3M Q2 '24: 3.8M Q3 '24: 4.2M Q4 '24: 4.3M Q1 '25: 4.2M Q2 '25: 4.4M Q3 '25: 4.4M Q4 '25: 4.7M Q1 '26: 5.1M Q2 '26: 5.4M Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Gross Profit TTM

0 150K 300K 450K Q2 '22: 320K Q3 '22: 196K Q4 '22: 8K Q2 '22 Q3 '22 Q4 '22

Operating Income TTM

-60M -40M -20M 0 20M 40M 60M Q3 '21: -18.9M Q4 '21: -27.4M Q1 '22: -36M Q2 '22: -44.6M Q3 '22: -52.5M Q4 '22: -56.3M Q1 '23: -58.3M Q2 '23: -55.3M Q3 '23: -52M Q4 '23: -48.5M Q1 '24: -45M Q2 '24: -44.6M Q3 '24: -45.1M Q4 '24: -46.1M Q1 '25: -47.7M Q2 '25: -47.9M Q3 '25: -48M Q4 '25: -49.6M Q1 '26: -49.3M Q2 '26: -50.7M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Net Income TTM

-75M -50M -25M 0 25M 50M 75M Q3 '21: -19.5M Q4 '21: -28.1M Q1 '22: -36.7M Q2 '22: -45.2M Q3 '22: -52.5M Q4 '22: -56.2M Q1 '23: -60.1M Q2 '23: -56.9M Q3 '23: -56.8M Q4 '23: -52.7M Q1 '24: -47M Q2 '24: -46.7M Q3 '24: -44.8M Q4 '24: -45.5M Q1 '25: -61.8M Q2 '25: -55.3M Q3 '25: -53.3M Q4 '25: -58M Q1 '26: -45M Q2 '26: -52.3M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Cost of Revenue TTM

0 350K 700K 1.1M Q2 '22: 954K Q3 '22: 809.7K Q4 '22: 369K Q2 '22 Q3 '22 Q4 '22

Operating Cash Flow TTM

-60M -40M -20M 0 20M 40M 60M Q3 '21: -9.5M Q4 '21: -17.7M Q1 '22: -20.1M Q2 '22: -31.1M Q3 '22: -35.3M Q4 '22: -29.7M Q1 '23: -31M Q2 '23: -24.7M Q3 '23: -27.1M Q4 '23: -32.8M Q1 '24: -38.3M Q2 '24: -42.9M Q3 '24: -44.2M Q4 '24: -44.1M Q1 '25: -44M Q2 '25: -43.1M Q3 '25: -43.8M Q4 '25: -46.5M Q1 '26: -46.1M Q2 '26: -46.9M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow TTM

-45M -30M -15M 0 15M 30M 45M Q4 '21: -18.5M Q1 '22: -21.1M Q2 '22: -34.2M Q3 '22: -39.3M Q4 '22: -32.9M Q1 '23: -34.1M Q4 '21 Q1 '22 Q2 '22 Q3 '22 Q4 '22 Q1 '23

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 70M 140M 210M Q1 '21: 14.1M Q2 '21: 14.1M Q3 '21: 14.1M Q1 '22: 35.1M Q2 '22: 35.8M Q3 '22: 36.4M Q1 '23: 41M Q2 '23: 41.8M Q3 '23: 41.9M Q1 '24: 45M Q2 '24: 48.2M Q3 '24: 50.4M Q1 '25: 68.8M Q2 '25: 99M Q3 '25: 108.2M Q1 '26: 140.1M Q2 '26: 183.1M Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-1.80 -1.20 -0.60 0.00 0.60 1.20 1.80 Q3 '21: -1.39 Q4 '21: -1.51 Q1 '22: -1.60 Q2 '22: -1.57 Q3 '22: -1.47 Q4 '22: -1.55 Q1 '23: -1.60 Q2 '23: -1.46 Q3 '23: -1.41 Q4 '23: -1.26 Q1 '24: -1.26 Q2 '24: -1.22 Q3 '24: -1.13 Q4 '24: -1.06 Q1 '25: -1.18 Q2 '25: -1.03 Q3 '25: -0.88 Q4 '25: -0.80 Q1 '26: -0.45 Q2 '26: -0.45 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.